While the company gained overall, its orthopedics business suffered, and CEO Olivier Bohuon said the company will be taking steps to reduce a cost base in orthopedics that is too high for ongoing market conditions. The company’s orthopedic business reported $548 million, only a 3 percent increase over the third quarter of last year.
The orthopedic reconstruction business grew by 2 percent, offset by a 2 percent decrease in the hip business. The knee and trauma businesses carried the orthopedics business, growing by 6 percent and 4 percent respectively. The company’s endoscopy business grew by 7 percent to $226 million.
Related Articles on Orthopedic Device Companies:
Lanx Names Dr. Ryan DenHaese Medical Education Director for New Training Program
LDR Receives FDA Clearance for Oblique ALIF Cage
Globus Medical Highlights 4 New Spine Devices
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
